Research records indexed for Capromorelin

This page carries 12 of the 40 records that the literature query returned for Capromorelin, selected by citation count and preferring records that name the compound in their title. It is a selection, not a complete index, and the 28 records it does not carry are not represented here. Every row resolves to a real identifier and names the study model, so no finding reads as a human claim by default. The compound page is Capromorelin.

Indexed records

Records retrieved for Capromorelin, newest first
RecordYearStudy typeModeln as statedWhat it reported
Capromorelin promotes weight gain in cats with unintended weight loss: a randomized, masked, placebo-controlled clinical trial pmid:412048152025Randomized Controlled Trial, Veterinary, research-articleotherNot statedIndexed as randomized controlled trial, veterinary, research-article. study model from MeSH "Animals" with no rodent species heading. subject headings: Cats; Cat Diseases; Weight Gain; Weight Loss; Piperidines.
Design, Biological Characterization, and Discovery of Capromorelin Derivatives as Oral Growth Hormone Secretagogue Receptor Type 1a Agonist for the Treatment of Growth Hormone Deficiency pmid:400912122025Journal ArticlerodentNot statedIndexed as journal article. study model from MeSH "Rats". subject headings: Dogs; Rats, Sprague-Dawley; Growth Hormone; Human Growth Hormone; Administration, Oral.
Effects of Capromorelin, Mirtazapine, and Cyproheptadine on Food Intake in Budgerigars (<i>Melopsittacus undulatus</i>) pmid:406381352025Randomized Controlled Trial, VeterinaryotherNot statedIndexed as randomized controlled trial, veterinary. study model from MeSH "Animals" with no rodent species heading. subject headings: Melopsittacus; Isoxazoles; Cyproheptadine; Appetite Stimulants; Cross-Over Studies.
The 4 prokinetic drugs metoclopramide, cisapride, pyridostigmine, and capromorelin do not increase fecal output or food intake in healthy New Zealand rabbits (Oryctolagus cuniculus) pmid:401799722025Research Support, Non-U.S. Gov't, Randomized Controlled Trial, VeterinaryotherNot statedIndexed as research support, non-u.s. gov't, randomized controlled trial, veterinary. study model from MeSH "Animals" with no rodent species heading. subject headings: Feces; Rabbits; Cisapride; Metoclopramide; Pyridostigmine Bromide.
Effect of Capromorelin on Appetite and Weight Gain of Domestic Pigeons (<i>Columba livia domestica</i>) pmid:397723802025Randomized Controlled Trial, VeterinaryotherNot statedIndexed as randomized controlled trial, veterinary. study model from MeSH "Animals" with no rodent species heading. subject headings: Columbidae; Weight Gain; Piperidines; Pyrazoles; Appetite Stimulants.
Insights on discovery, efficacy, safety and clinical applications of ghrelin receptor agonist capromorelin in veterinary medicine pmid:374939402024ReviewotherNot statedIndexed as review. study model from MeSH "Animals" with no rodent species heading. subject headings: Mammals; Dogs; Piperidines; Pyrazoles; Growth Hormone.
Evaluating the Safety and Efficacy of Capromorelin in Rhesus Macaques (<i>Macaca mulatta</i>) pmid:384235292024research-article, Research Support, N.I.H., ExtramuralotherNot statedIndexed as research-article, research support, n.i.h., extramural. study model from MeSH "Animals" with no rodent species heading. subject headings: Macaca Mulatta; Body Weight; Weight Gain; Weight Loss; Piperidines.
Investigating the Effect of Enterally Administered Capromorelin on Body Weight in Mice (Mus musculus) pmid:390256622024research-articlerodentNot statedIndexed as research-article. study model from MeSH "Mice, Inbred Balb C". subject headings: Mice, Inbred BALB C; Body Weight; Weight Loss; Bupivacaine; Buprenorphine.
Detection of capromorelin in urine following oral and dermal routes of administration pmid:376883592023Journal ArticleotherNot statedIndexed as journal article. study model from MeSH "Animals" with no rodent species heading. subject headings: Dogs; Piperidines; Pyrazoles; Growth Hormone; Administration, Oral.
Comparison of Effects of Capromorelin and Mirtazapine on Appetite in New Zealand White Rabbits (<i>Oryctolagus cuniculus)</i> pmid:359818572022Research Support, Non-U.S. Gov't, Randomized Controlled Trial, VeterinaryotherNot statedIndexed as research support, non-u.s. gov't, randomized controlled trial, veterinary. study model from MeSH "Animals" with no rodent species heading. subject headings: Rabbits; Piperidines; Pyrazoles; Appetite Stimulants; Appetite.
The effect of capromorelin on glycemic control in healthy dogs pmid:356899532022Research Support, Non-U.S. Gov'totherNot statedIndexed as research support, non-u.s. gov't. study model from MeSH "Animals" with no rodent species heading. subject headings: Dogs; Cats; Piperidines; Pyrazoles; Gastric Inhibitory Polypeptide.
Capromorelin, a ghrelin receptor agonist, increases feed intake and body weight gain in broiler chickens (Gallus gallus domesticus) pmid:341822192021Randomized Controlled Trial, Veterinary, research-articleotherNot statedIndexed as randomized controlled trial, veterinary, research-article. study model from MeSH "Animals" with no rodent species heading. subject headings: Chickens; Body Weight; Weight Gain; Piperidines; Pyrazoles.

Where this page sits

Compound page: Capromorelin. Class: Growth hormone secretagogues.

Retrieved 2026-10-12.

Sources

  1. PubChem Compound Summary for CID 216208, Capromorelin. PubChem, National Library of Medicine (2026). pubchem:216208
  2. Drugs@FDA application register query for this compound, no application records returned. U.S. Food and Drug Administration, openFDA drugsfda endpoint (2026). fda:capromorelin
  3. Pyrazolinone-piperidine dipeptide growth hormone secretagogues (GHSs). Discovery of capromorelin. Bioorganic & medicinal chemistry (2003). pmid:12538023
  4. Discovery and biological characterization of capromorelin analogues with extended half-lives. Bioorganic & medicinal chemistry letters (2002). pmid:12392732
  5. Pharmacokinetics of the ghrelin agonist capromorelin in a single ascending dose Phase-I safety trial in spinal cord-injured and able-bodied volunteers. Spinal cord (2015). pmid:25448190
  6. Capromorelin: a ghrelin receptor agonist and novel therapy for stimulation of appetite in dogs. Veterinary medicine and science (2018). pmid:29468076
  7. A Prospective, Randomized, Masked, Placebo-Controlled Clinical Study of Capromorelin in Dogs with Reduced Appetite. Journal of veterinary internal medicine (2016). pmid:27859746
  8. Capromorelin oral solution (ENTYCE®) increases food consumption and body weight when administered for 4 consecutive days to healthy adult Beagle dogs in a randomized, masked, placebo controlled study. BMC veterinary research (2017). pmid:28056951
  9. Capromorelin increases food consumption, body weight, growth hormone, and sustained insulin-like growth factor 1 concentrations when administered to healthy adult Beagle dogs. Journal of veterinary pharmacology and therapeutics (2017). pmid:27597271
  10. Evaluation of the safety of daily administration of capromorelin in cats. Journal of veterinary pharmacology and therapeutics (2018). pmid:29057482
  11. Capromorelin, a ghrelin receptor agonist, increases feed intake and body weight gain in broiler chickens (Gallus gallus domesticus). Poultry science (2021). pmid:34182219

On each stated value was matched to the record cited for it. That is record matching, not an appraisal of the research. Compiled and checked by: Peptide Monographs editorial desk. No qualified clinical reviewer.

Related resources